| Literature DB >> 31703370 |
Dongdong Zhang1, Yanhong Shi2, Jingyi Li1, Deqing Ruan1, Qi Jia1, Weiliang Zhu3, Kaixian Chen1,3, Yiming Li1, Rui Wang1.
Abstract
As our ongoing research project on Ban Lan Gen (Isatis tinctoria roots), a total of 23 alkaloids were obtained. Compounds 1 and 2 contain an unusual C-C bond between the 2(1H)-quinolinone moiety and the phenol moiety and between the 2(1H)-quinolinone moiety and the 1H-indole moiety, respectively. Compound 3 possesses an unusual carbon skeleton and its putative biosynthetic pathway was discussed, and Compound 23 was deduced as a new indole alkaloid glycoside. Compounds 4-7 were identified as four new natural products by extensive spectroscopic experiments. Additionally, the anti-inflammatory activity was assessed based on nitric oxide (NO) production using Lipopolysaccharide-stimulated RAW264.7 macrophages. Compounds 9, 15, and 17 showed inhibitory effects with IC50 values of 1.2, 5.0, and 74.4 μM.Entities:
Keywords: Isatis tinctoria roots; alkaloids; anti-inflammatory activity; structure identification
Mesh:
Substances:
Year: 2019 PMID: 31703370 PMCID: PMC6891263 DOI: 10.3390/molecules24224033
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of Compounds 1–23.
1H-NMR (600 MHz in DMSO-d6) and 13C-NMR data (150 MHz in DMSO-d6) of 1–3.
| No. | 1 | 2 | 3 | |||
|---|---|---|---|---|---|---|
| 1 | 10.19, s | 12.06, brs | ||||
| 2 | 169.5 | 168.3 | 156.8 | |||
| 3 | 7.48, s | 136.7 | 8.63, s | 130.6 | ||
| 4 | 126.1 | 118.8 | 160.5 | |||
| 4a | 122.5 | 116.8 | 120.3 | |||
| 5 | 7.20, d (2.2) | 110.1 | 155.0 | 8.13, d (8.0) | 126.3 | |
| 6 | 152.2 | 6.67, d (7.5) | 102.6 | 7.47, dd (8.0, 7.2) | 126.0 | |
| 7 | 6.63, dd (8.3, 2.2) | 110.7 | 7.15, overlap | 123.9 | 7.82, dd (8.1, 7.2) | 134.9 |
| 8 | 6.66, d (8.3) | 116.5 | 6.85, d (7.3) | 106.2 | 7.72, d (8.1) | 126.2 |
| 8a | 135.4 | 138.0 | 148.8 | |||
| 1’ | 125.4 | 10.51, s | 11.98, brs | |||
| 2’ | 7.57, d (8.5) | 132.1 | 112.5 | 7.84, d (2.2) | 128.3 | |
| 3’ | 6.90, d (8.5) | 116.1 | 9.45, s | 133.5 | 112.5 | |
| 3’a | 126.3 | 127.4 | ||||
| 4’ | 159.6 | 7.50, d (7.5) | 117.9 | 7.87, d (7.5) | 118.5 | |
| 5’ | 6.90, d (8.5) | 116.1 | 7.15, overlap | 121.1 | 7.22, dd (8.1, 7.5) | 120.9 |
| 6’ | 7.57, d (8.5) | 132.1 | 7.00, dd (7.5, 7.4) | 127.0 | 7.25, dd (8.1, 7.5) | 123.0 |
| 7’ | 7.14, overlap | 109.5 | 7.50, d (7.5) | 112.6 | ||
| 7’a | 139.4 | 136.4 | ||||
| 1’’ | 8.13, s | 122.6 | ||||
| 2’’ | 125.6 | |||||
| 3’’ | 3.17, 2H, m | 26.2 | ||||
| 4’’ | 4.25, 2H, t (7.0) | 44.7 | ||||
| OMe | 4.04, s | 55.9 | ||||
| 6-OH | 10.12, s | |||||
| 4’-OH | 8.96, s | |||||
Figure 2Key 1H-1H COSY and HMBC correlations of Compounds 1–3 and 23.
1H-NMR (600 MHz in DMSO-d6) and 13C-NMR data (150 MHz in DMSO-d6) of 23.
| No. | 23 | No. | 23 | ||
|---|---|---|---|---|---|
|
|
| ||||
| 1a | 7.45, brs | 172.9 | 3’’ | 112.1 | |
| 1b | 7.14, brs | 3’’a | 126.7 | ||
| 2 | 5.68, s | 38.7 | 4’’ | 7.56, d (8.0) | 118.4 |
| 1’ | 10.35, brs | 5’’ | 6.93, dd (8.0, 7.1) | 118.9 | |
| 2’ | 126.8 | 6’’ | 7.04, dd (8.1, 7.1) | 120.5 | |
| 3’ | 133.0 | 7’’ | 7.32, d (8.1) | 111.4 | |
| 3’a | 121.2 | 7’’a | 136.0 | ||
| 4’ | 7.77, d (8.0) | 118.1 | Glc-1 | 4.63, d (7.8) | 106.6 |
| 5’ | 6.92, dd (8.0, 7.2) | 118.4 | 2 | 3.38, overlap | 74.1 |
| 6’ | 6.97, dd (8.1, 7.2) | 120.8 | 3 | 3.26, m | 76.8 |
| 7’ | 7.26, d (8.1) | 111.6 | 4 | 3.28, m | 69.8 |
| 7’a | 133.3 | 5 | 3.14, m | 77.2 | |
| 1’’ | 10.94, brs | 6a | 3.56, dd (10.8, 5.6) | 61.0 | |
| 2’’ | 7.38, s | 123.9 | 6b | 3.67, dd (10.8, 1.8) | |
Figure 3Experimental and calculated ECD spectra of 23.
NO inhibitory activities of Compounds 1–23 in RAW 264.7 cell line.
| Compounds | IC50 a | Cytotoxicity | Compounds | IC50 a | Cytotoxicity |
|---|---|---|---|---|---|
|
| >100 | >100 |
| >100 | >100 |
|
| >100 | >100 |
| >100 | >100 |
|
| >100 | >100 |
| 5.0 ± 1.3 | >100 |
|
| >100 | >100 |
| >100 | >100 |
|
| >100 | >100 |
| 74.4 ± 3.8 | >100 |
|
| >100 | >100 |
| >100 | >100 |
|
| >100 | >100 |
| >100 | >100 |
|
| >100 | >100 |
| >100 | >100 |
|
| 1.2 ± 0.9 | >25 |
| >100 | >100 |
|
| >100 | >100 |
| >100 | >100 |
|
| >100 | >100 |
| >100 | >100 |
|
| >100 | >100 | AG b | 22.7 ± 0.4 | >100 |
a IC50 values were expressed as mean ± SD (n = 3). b AG = aminoguanidine hydrochloride was used as the positive control.
Figure 4Putative biosynthetic pathway of 3.